Monoacylglycerol Lipase Inhibitor JJKK048 Ameliorates ABCG2 Transporter-Mediated Regorafenib Resistance Induced by Hypoxia in Triple Negative Breast Cancer Cells

Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs

(2022) Feng Deng et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Increased Expression and Activity of Brain Cortical cPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer’s Disease

(2022) Mikko Gynther et al.   Pharmaceutics

Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer

(2021) Milica Nedeljković et al.   Breast Cancer

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Triple‑negative breast cancer: A run‑through of features, classification and current therapies (Review)

(2021) Meghana Manjunath et al.   Oncology Letters

Systemic inflammation induced changes in protein expression of ABC transporters and ionotropic glutamate receptor subunit 1 in the cerebral cortex of familial Alzheimer`s disease mouse model

(2021) Elena Puris et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

(2021) Sergiusz Łukasiewicz et al.   Cancers

Breast Cancer Treatments: Updates and New Challenges

(2021) Anna Burguin et al.   Journal of Personalized Medicine

Evolving role of regorafenib for the treatment of advanced cancers

(2020) Axel Grothey et al.   CANCER TREATMENT REVIEWS

Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage

(2020) Meghna Mehta et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Role of Cellular, Molecular, and Tumor Microenvironment in Hepatocellular Carcinoma: Possible Targets and Future Directions in the Regorafenib Era

(2020) Sarun Juengpanich et al.   INTERNATIONAL JOURNAL OF CANCER

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer

(2020) Ellen C. de Heer et al.   JOURNAL OF CLINICAL INVESTIGATION

The Ultimate qPCR Experiment: Producing Publication Quality, Reproducible Data the First Time

(2019) Sean C. Taylor et al.   TRENDS IN BIOTECHNOLOGY

Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment

(2019) Ana C. Garrido-Castro et al.   Cancer Discovery

Monoacylglycerol lipase inhibitors: Modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders

(2019) Hui Deng et al.   Acta Pharmaceutica Sinica B

Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes

(2018) I. Chae Ye et al.   MOLECULAR CANCER RESEARCH

The use of cobalt chloride as a chemical hypoxia model

(2018) Jorge Muñoz-Sánchez et al.   JOURNAL OF APPLIED TOXICOLOGY

Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist

(2017) Mikko Gynther et al.   JOURNAL OF MEDICINAL CHEMISTRY

Transmembrane Domain Single-Nucleotide Polymorphisms Impair Expression and Transport Activity of ABC Transporter ABCG2

(2017) Noora Sjöstedt et al.   PHARMACEUTICAL RESEARCH

The molecular mechanisms of chemoresistance in cancers

(2017) Hua-Chuan Zheng   Oncotarget

Hypoxia regulates ABCG2activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells

(2016) Xiaodan He et al.   CANCER BIOLOGY & THERAPY

Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition

(2016) Weiping Zhu et al.   Journal of Hematology & Oncology

Inhibition of Breast Cancer Resistance Protein and Multidrug Resistance Associated Protein 2 by Natural Compounds and Their Derivatives

(2016) Noora Sjöstedt et al.   MOLECULAR PHARMACEUTICS

Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors

(2016) Claudia Neul et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis

(2016) Jung-Chen Su et al.   Scientific Reports

Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1)

(2015) Anita Kort et al.   PHARMACEUTICAL RESEARCH

Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy

(2014) Wei Wang et al.   CURRENT MEDICINAL CHEMISTRY

Piperazine and Piperidine Triazole Ureas as Ultrapotent and Highly Selective Inhibitors of Monoacylglycerol Lipase

(2013) Niina Aaltonen et al.   CHEMISTRY & BIOLOGY

Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma

(2013) Yingjian Liang et al.   HEPATOLOGY

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

(2012) Karthika Natarajan et al.   BIOCHEMICAL PHARMACOLOGY

HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast

(2012) Sophie Doublier et al.   BMC CANCER

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

(2011) C. C.-L. Wong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer

(2009) B. K. Linderholm et al.   ANNALS OF ONCOLOGY

Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis

(2009) Daniel K. Nomura et al.   CELL